In what’s viewed as a significant step toward addressing unmet needs in California’s sickle cell disease (SCD) community, scientists…
Mary Chapman
Mary graduated from Wayne State University with a degree in journalism. She began her career at United Press International, then spent a decade reporting for the Bureau of National Affairs, Inc. (now Bloomberg Industry Group). Mary has written extensively for The New York Times, and her work has appeared in publications such as Time, Newsweek, Fortune, and the Chicago Tribune. She’s won a Society of Professional Journalists award for outstanding reporting.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Mary Chapman
Backed by a new study suggesting that sickle cell disease (SCD) is common among refugees in Southern Europe,…
In an effort to raise awareness about the latest in sickle cell disease therapy, Emmy award-winning National Football League…
A Republic of Congo delegation of health and higher education representatives recently met with Howard University officials, aiming to ultimately…
Scores of events are afoot worldwide to mark Feb. 28, Rare Disease Day 2019. The activities aim to raise awareness about…
For eligible sickle cell disease (SCD) patients covered by commercial insurance, biopharmaceutical company Emmaus Life Sciences will offer financial…
The U.S. Food and Drug Administration(FDA) is updating its 2015 draft guidelines for drug discovery in rare diseases, with…
The Sickle Cell Foundation of Georgia (SCFG) will host its 42nd Annual Camp New Hope July 14-20 for…
Howard University President Wayne A.I. Frederick has unveiled a campaign to raise awareness and funds for the school’s Center for…
For this year’s Solutions to Empower Patients (STEP) program, global healthcare company Novartis has announced it will fund up…